Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Archimbaud

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Blood|May 15, 1992
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle OsseuseD Blaise, D Maraninchi, E Archimbaud, et al.
Blood|December 15, 1993
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemiaS Castaigne, P Lefebvre, C Chomienne, et al.
Leukemia|October 27, 1997
Molecular analysis of cyclin-dependent kinase inhibitors in human leukemiasS Hayette, X Thomas, Y Bertrand, et al.
Presse Medicale (Paris, France : 1983)|October 8, 1983
[Highly malignant non-Hodgkin's lymphoma. Treatment by intensive sequential chemotherapy]B Coiffier, P A Bryon, D Fière, et al.
Bone Marrow Transplantation|June 1, 1995
Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de MoelleA Pigneux, A Devergie, M Pochitaloff, et al.
Nouvelle Revue Francaise D'Hematologie|July 1, 1994
[Sequential chemotherapy with or without GM-CSF in acute myeloid leukemia (AML) in the advanced phase: current status of protocols EMA 86 and EMA 91]E Archimbaud, V Leblond, P Fenaux, et al.
Leukemia|June 9, 1999
Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemiaE Archimbaud, U Jehn, X Thomas, et al.
Blood|June 15, 1994
Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemiasR Rimokh, F Berger, C Bastard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80)B Coiffier, P A Bryon, F Berger, et al.
Blood|December 1, 1993
Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 GroupP Fenaux, M C Le Deley, S Castaigne, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Blood|May 15, 1992
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle OsseuseD Blaise, D Maraninchi, E Archimbaud, et al.
Blood|December 15, 1993
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemiaS Castaigne, P Lefebvre, C Chomienne, et al.
Leukemia|October 27, 1997
Molecular analysis of cyclin-dependent kinase inhibitors in human leukemiasS Hayette, X Thomas, Y Bertrand, et al.
Presse Medicale (Paris, France : 1983)|October 8, 1983
[Highly malignant non-Hodgkin's lymphoma. Treatment by intensive sequential chemotherapy]B Coiffier, P A Bryon, D Fière, et al.
Bone Marrow Transplantation|June 1, 1995
Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de MoelleA Pigneux, A Devergie, M Pochitaloff, et al.
Nouvelle Revue Francaise D'Hematologie|July 1, 1994
[Sequential chemotherapy with or without GM-CSF in acute myeloid leukemia (AML) in the advanced phase: current status of protocols EMA 86 and EMA 91]E Archimbaud, V Leblond, P Fenaux, et al.
Leukemia|June 9, 1999
Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemiaE Archimbaud, U Jehn, X Thomas, et al.
Blood|June 15, 1994
Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemiasR Rimokh, F Berger, C Bastard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80)B Coiffier, P A Bryon, F Berger, et al.
Blood|December 1, 1993
Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 GroupP Fenaux, M C Le Deley, S Castaigne, et al.
Pageof 13